Yüklüyor......
Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype
BACKGROUND: Sustained use of oral corticosteroids is associated with significant side effects. It is therefore of interest to find a corticosteroid-sparing agent. In two meta-analyses, methotrexate resulted in a rather small reduction in the oral corticosteroid maintenance dose. We have used methotr...
Kaydedildi:
| Yayımlandı: | Eur Clin Respir J |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Co-Action Publishing
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4629721/ https://ncbi.nlm.nih.gov/pubmed/26557239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/ecrj.v1.25037 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|